Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity.
J Thromb Thrombolysis. 2008.
PMID: 18360788
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1999 | 3 |
| 2000 | 5 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 7 |
| 2016 | 1 |
| 2017 | 1 |
| 2023 | 1 |
| 2024 | 0 |
Search Results
40 results
Results by year
Citations
4
articles
found by citation matching
Mesenteric vein thrombosis secondary to combined protein C deficiency and double heterozygosity for factor V Leiden and prothrombin G20210A.
Am J Hematol. 1999.
PMID: 10539890
No abstract available.
The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism.
Cureus. 2023.
PMID: 37809238
Free PMC article.
Search results
Page 1
Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
J Thromb Haemost. 2016 Jul;14(7):1393-403. doi: 10.1111/jth.13349. Epub 2016 Jun 16.
J Thromb Haemost. 2016.
PMID: 27121914
Free article.
Review.
The results support discouraging COC-use in women with a natural anticoagulant deficiency. Contrary, additive risk of factor V Leiden (FVL) or prothrombin-G20210A (PT) mutation is modest. ...Methods The MEDLINE and EMBASE databases were searched …
The results support discouraging COC-use in women with a natural anticoagulant deficiency. Contrary, additive risk of factor V …
The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism.
Cureus. 2023 Sep 7;15(9):e44835. doi: 10.7759/cureus.44835. eCollection 2023 Sep.
Cureus. 2023.
PMID: 37809238
Free PMC article.
Anticoagulation therapy remains the cornerstone of venous thromboembolism management, and the duration of anticoagulation depends on the risk of venous thromboembolism. We report a case of a female with a combined heterozygosity of factor V Leiden …
Anticoagulation therapy remains the cornerstone of venous thromboembolism management, and the duration of anticoagulation depends on the ris …
Combined factor V leiden (G1691A) and prothrombin (G20210A) genotyping by multiplex real-time polymerase chain reaction using fluorescent resonance energy transfer hybridization probes on the Rotor-Gene 2000.
Blood Coagul Fibrinolysis. 2003 Jun;14(4):421-4. doi: 10.1097/00001721-200306000-00016.
Blood Coagul Fibrinolysis. 2003.
PMID: 12945887
Most are based on PCR followed by restriction enzyme digestion and electrophoresis (RFLP), but gel analysis has certain limitations, and alternative detection methods, including real-time PCR, have therefore been developed. In this study we developed and evaluated a combined …
Most are based on PCR followed by restriction enzyme digestion and electrophoresis (RFLP), but gel analysis has certain limitations, and alt …
Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.
Clin Hemorheol Microcirc. 2017;67(3-4):261-266. doi: 10.3233/CH-179207.
Clin Hemorheol Microcirc. 2017.
PMID: 28869458
Furthermore, 3 cases with combined heterozygosity of factor V Leiden- and prothrombin-mutation have been identified in CVT, but not in AIS or controls. ...Also, the combined occurrence of heterozygous prothrombin- and fac …
Furthermore, 3 cases with combined heterozygosity of factor V Leiden- and prothrombin-mutation hav …
Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity.
J Thromb Thrombolysis. 2008 Aug;26(1):31-4. doi: 10.1007/s11239-008-0214-1. Epub 2008 Mar 23.
J Thromb Thrombolysis. 2008.
PMID: 18360788
Skin biopsy showed inflammatory infiltrate with epidermal necrosis. Prothrombin G20210A and factor V-Leiden heterozygosity, and MTHFR C677T homozygosity with hyperhomocysteinemia were confirmed. LV diagnosis was made; acetylsalicylic acid …
Skin biopsy showed inflammatory infiltrate with epidermal necrosis. Prothrombin G20210A and factor V-Leiden …
Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.
Stroke. 2000 Jun;31(6):1283-8. doi: 10.1161/01.str.31.6.1283.
Stroke. 2000.
PMID: 10835445
METHODS: Patients and control subjects were tested for antithrombin protein C and protein S deficiencies, the presence of antiphospholipid antibodies (APLA), factor V Leiden (FVL), G20210A polymorphism of factor II gene (FII G20210A), and C677T …
METHODS: Patients and control subjects were tested for antithrombin protein C and protein S deficiencies, the presence of antiphospholipid a …
Combined heterozygosity of factor V leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis.
Am J Hematol. 2000 Jul;64(3):226-8. doi: 10.1002/1096-8652(200007)64:3<226::aid-ajh17>3.0.co;2-f.
Am J Hematol. 2000.
PMID: 10861823
Free article.
Cerebral venous thrombosis (CVT) is a rare type of stroke with a variety of causes. Several reports have suggested that either factor V Leiden or G20210A prothrombin gene mutation is associated with an increased risk of CVT. The genetic thrombop …
Cerebral venous thrombosis (CVT) is a rare type of stroke with a variety of causes. Several reports have suggested that either factor …
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Thromb Haemost. 2001 Sep;86(3):809-16.
Thromb Haemost. 2001.
PMID: 11583312
Factor V Leiden and factor II G20210A mutations are two frequent genetic risk factors involved in venous thromboembolism (VTE). ...The odds ratio for venous thrombosis in double heterozygotes was 20.0 (11.1-36.1). Twelve percent of patients heterozygou …
Factor V Leiden and factor II G20210A mutations are two frequent genetic risk factors involved in venous thrombo …
Combined factor V Leiden and prothrombin genotyping in patients presenting with thromboembolic episodes.
Arch Pathol Lab Med. 2001 Jan;125(1):105-11. doi: 10.5858/2001-125-0105-CFVLAP.
Arch Pathol Lab Med. 2001.
PMID: 11151062
Free article.
BACKGROUND: Several genetic defects are associated with increased risk of venous thrombosis. The factor V Leiden (FVL) and prothrombin G20210A mutations are the most frequent causes of inherited thrombophilia. ...Two cases (0.5%) were identified …
BACKGROUND: Several genetic defects are associated with increased risk of venous thrombosis. The factor V Leiden (FVL) …
Oral contraception in women with mild thrombophilia: what have we learned recently?
Thromb Res. 2012 Oct;130 Suppl 1:S16-8. doi: 10.1016/j.thromres.2012.08.263.
Thromb Res. 2012.
PMID: 23026651
Review.
Mild thrombophilias include heterozygous forms of Factor V Leiden and prothrombin G20210A mutation and high levels of factor VIII. These defects are responsible for only a moderate increase of venous thromboembolism (VTE) risk compared with stro …
Mild thrombophilias include heterozygous forms of Factor V Leiden and prothrombin G20210A mutation and hi …
Cite